Radioimmunotherapy Of Non-Hodgkin'S Lymphoma

Course overview

This tutorial is related to Radioimmunotherapy of non-Hodgkin's Lymphoma and gives an overview of its role in Nuclear Medicine. At the conclusion of this presentation, attendees should be able 1.Name the two radiopharmaceuticals approved by the FDA for performance of RIT Procedures 2.Describe how patient- specific doses are determined and identify the typical dose for each radiopharmaceutical 3.List several eligibility criteria for undergoing the RIT procedure 4.Name the pretreatment designed specifically for Bexxar 5.Describe the special radiation safety considerations when administering Bexxar to patients 6.Briefly describe the results of clinical trials in the US for the past 10 years 7.List potential long-term effects that could result from this treatment